Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.61 USD | -3.83% | -4.81% | +613.09% |
Apr. 30 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
Apr. 30 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
Financials (USD)
Sales 2024 * | 243M | Sales 2025 * | 274M | Capitalization | 513M |
---|---|---|---|---|---|
Net income 2024 * | -77M | Net income 2025 * | -46M | EV / Sales 2024 * | 2.11 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.88 x |
P/E ratio 2024 * |
-6.83
x | P/E ratio 2025 * |
-12.5
x | Employees | 1,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.69% |
Latest transcript on GeneDx Holdings Corp.
1 day | -3.83% | ||
1 week | -4.81% | ||
1 month | -6.26% | ||
3 months | +130.16% | ||
6 months | +989.44% | ||
Current year | +613.09% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 22-04-28 | |
Kevin Feeley
DFI | Director of Finance/CFO | 43 | - |
Paul Kruszka
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Joshua Ruch
BRD | Director/Board Member | 74 | 21-07-21 |
Director/Board Member | 68 | 22-04-30 | |
Keith Meister
BRD | Director/Board Member | 51 | 20-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 19.61 | -3.83% | 323,885 |
24-05-30 | 20.39 | -3.59% | 256,811 |
24-05-29 | 21.15 | +3.02% | 426,463 |
24-05-28 | 20.53 | -0.34% | 387,001 |
24-05-24 | 20.6 | +4.46% | 385,721 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+613.09% | 513M | |
-24.16% | 7.76B | |
+68.65% | 4.33B | |
-2.98% | 2.64B | |
+2.72% | 2.63B | |
-46.17% | 2.16B | |
-22.12% | 1.46B | |
+13.62% | 1.17B | |
-43.81% | 1.14B | |
+20.41% | 999M |
- Stock Market
- Equities
- WGS Stock